A comprehensive view of men's health issues. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
AstraZeneca Submits Patent Application for Methods of Treating Prostate Cancer
Published:
July 15, 2024
by Medical Patent News
|
Merck and Orion exercise option granting Merck exclusive global rights to Opevesostat for prostate cancer; Merck to assume full development costs, Orion eligible for up to $1.63 billion in milestone payments
Published:
July 01, 2024
by Merck & Co. Inc.
|
Janssen spearheads innovations in cancer with chemotherapy-free NSCLC regimen; company champions transgender-inclusive protocols in prostate cancer and presents new data on neurological disorders at EAN 2024
Published:
June 29, 2024
by Industry Intelligence Inc.
|
US Patent Issued to Bristol-Myers Squibb on June 25 for "Methods of treating prostate cancer" (California Inventors)
Published:
June 26, 2024
by U.S. Fed News
|
BioNTech and DualityBio receive FDA Fast Track designation for BNT324/DB-1311 in prostate cancer; third asset in collaboration to receive Fast Track, with 5-year survival rate of 36% for patients with metastatic CRPC.
Published:
June 24, 2024
by BioNTech SE
|
Ask us about our Consumer Wellness market view
Trending Chart
Interactive chart with headline count